-logo.PNG?v=20210211152252 "Profound Medical Corp. logo"){kind=logo}
Raymond James Financial upgraded shares of Profound Medical (TSE:PRN – Free Report) from a moderate buy rating to a strong-buy rating in a report released on Monday morning,Zacks.com reports.
Profound Medical Trading Up 1.6%
TSE PRN opened at C$10.44 on Monday. The company has a quick ratio of 14.98, a current ratio of 6.56 and a debt-to-equity ratio of 12.56. Profound Medical has a 52 week low of C$5.23 and a 52 week high of C$12.40. The business has a 50 day moving average price of C$9.63 and a 200-day moving average price of C$9.45. The company has a market cap of C$379.37 million, a price-to-earnings ratio of -8.42 and a beta of 1.26.
Profound Medical (TSE:PRN – Get Free Report) last issued its earnings results on Thursday, May 7th. The company reported C$0.26 earnings per share (EPS) for the quarter. Profound Medical had a negative return on equity of 78.75% and a negative net margin of 206.94%.The company had revenue of C$7.42 million for the quarter. As a group, equities analysts expect that Profound Medical will post -1.9000001 earnings per share for the current fiscal year.
Profound Medical Company Profile
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum.
Featured Articles
- Five stocks we like better than Profound Medical
- AirJoule’s Kubota Deal Is a Major Validation—But the Hard Part Comes Next
- Dividend Stocks May Be the Quiet Rotation Trade Investors Are Missing Now
- Refiner Stocks Are Near Record Highs—Can Iran-Driven Margins Keep Them There?
- Verizon May Be an AI Infrastructure Stock Hiding in Plain Sight
Receive News & Ratings for Profound Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Profound Medical and related companies with MarketBeat.com's FREE daily email newsletter.
